Fundraising Fox
Omeza Holdings
Sarasota, US · Founded 2022 · Delaware corporation · 19 employees on LinkedIn · 4 known investors
Find your way into Omeza Holdings
Sign up to see every warm intro you have to Omeza Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Omeza Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Omeza is an ocean biotechnology company developing marine-based regenerative wound-care products, including its FDA-cleared OCM wound matrix made from cold-water fish peptides, omega fatty acids, and plant-derived lipids, to treat chronic, hard-to-heal wounds such as diabetic foot ulcers and venous leg ulcers in adults. The commercial-stage company serves the U.S. advanced wound care market and markets its products to clinical care sites.
Founders & leadership
RG
Ronald GelbmanNamed on SEC filing
TG
Thomas GardnerNamed on SEC filing
JM
Joel MorganrothNamed on SEC filing
RE
Robert EssnerNamed on SEC filing
Board
AL
AG LafleyBoard director
RH
Richard HagueBoard director
FM
Frank MartuciBoard director
Investors · 4
Also in the syndicate · 2
AstanorleadBlukap Ventureslead
Funding
SEC filings, press & company announcements$22.3M disclosed across 5 rounds · 2022–2026
- $8.5MSeries aApr 2026 · 2 sources
Astanor (lead), Blukap Ventures (lead), Catalyst Investments
Source ↗
▶$906.3KraisedJan 2025 · 14 investors · Other Health CareRule 506(c)
▶$906.3KraisedJan 2025 · 14 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- AG LafleyDirector
- Cynthia FlowersExecutive Officer, Director
- Richard HagueDirector
- Frank MartuciDirector
- Offering amount
- $2.4M
- Amount sold
- $906.3K
- Minimum investment
- $12.5K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06c
▶$1.6MraisedSep 2023 · 12 investors · Other Health CareRule 506(b)
▶$1.6MraisedSep 2023 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joel MorganrothDirector
- Robert EssnerDirector
- AG LafleyDirector
- Cynthia FlowersExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $50K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$6.5MraisedSep 2023 · 39 investors · Other Health CareRule 506(b)
▶$6.5MraisedSep 2023 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert EssnerDirector
- Cynthia FlowersExecutive Officer, Director
- AG LafleyDirector
- Joel MorganrothDirector
- Offering amount
- $10M
- Amount sold
- $6.5M
- Minimum investment
- $25K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$4.8MraisedMar 2022 · 27 investors · Other Health CareRule 506(b)
▶$4.8MraisedMar 2022 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ronald GelbmanDirector
- Thomas GardnerExecutive Officer, Director
- Joel MorganrothDirector
- AG LafleyDirector
- Robert EssnerDirector
- Offering amount
- $5M
- Amount sold
- $4.8M
- Minimum investment
- $50K
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
PractoPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
1MgThis is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth. The page provides usage instructions, benefits, side effects, and purchase/return details rather than describing a company.
SoundCloudAudio distribution and music-sharing platform for artists and creators.
PharmEasyPharmEasy is a consumer healthcare platform offering on-demand home delivery of prescription and over-the-counter pharmaceuticals, diagnostic tests, and teleconsultation services in India.
Companies working in the same space as Omeza Holdings.
In the news
Frequently asked questions
- What does Omeza Holdings do?
- Omeza is an ocean biotechnology company developing marine-based regenerative wound-care products, including its FDA-cleared OCM wound matrix made from cold-water fish peptides, omega fatty acids, and plant-derived lipids, to treat chronic, hard-to-heal wounds such as diabetic foot ulcers and venous leg ulcers in adults. The commercial-stage company serves the U.S. advanced wound care market and markets its products to clinical care sites.
- Who are Omeza Holdings's investors?
- Omeza Holdings's investors include Florida Opportunity Fund, Catalyst Investments.
- How much funding has Omeza Holdings raised?
- Omeza Holdings has disclosed $22.3M raised across 5 rounds.
- Where is Omeza Holdings headquartered?
- Omeza Holdings is headquartered in Sarasota, US.